Aibotics Inc.

PINK:AIBT USA Biotechnology
Market Cap
$13.22 Million
Market Cap Rank
#37067 Global
#12055 in USA
Share Price
$0.03
Change (1 day)
-6.25%
52-Week Range
$0.03 - $0.06
All Time High
$0.06
About

Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Fl… Read more

Aibotics Inc. (AIBT) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.046x

Based on the latest financial reports, Aibotics Inc. (AIBT) has a cash flow conversion efficiency ratio of 0.046x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-178.72K) by net assets ($-3.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aibotics Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Aibotics Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Aibotics Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aibotics Inc. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Aibotics Inc. (2016–2024)

The table below shows the annual cash flow conversion efficiency of Aibotics Inc. from 2016 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-3.39 Million $-259.04K 0.076x +44.95%
2023-12-31 $-2.03 Million $-106.77K 0.053x -92.85%
2022-12-31 $-891.35K $-656.62K 0.737x +206.37%
2021-12-31 $340.02K $-235.48K -0.693x -3.91%
2020-12-31 $454.31K $-302.81K -0.667x -540.38%
2019-12-31 $651.90K $98.67K 0.151x +242.91%
2018-12-31 $647.10K $-68.53K -0.106x -126.03%
2017-12-31 $572.23K $232.82K 0.407x +92.08%
2016-12-31 $442.41K $93.71K 0.212x --